5 Very Cheap Stocks to Buy Right Now

In this article, we discuss the 5 very cheap stocks to buy right now. If you want to read our detailed analysis of these stocks, go directly to the 10 Very Cheap Stocks to Buy Right Now. 

5. Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Number of Hedge Fund Holders: 27    

Real-Time Share Price as of December 12: $20.88

Pacific Biosciences of California, Inc. (NASDAQ:PACB) develops sequencing systems for complex genetic problems. The company recently beat market estimates on earnings per share and revenue for the third quarter by $0.01 and $1.2 million respectively. 

In September, Canaccord analyst Kyle Mikson initiated coverage of Pacific Biosciences of California, Inc. (NASDAQ:PACB) stock with a Buy rating and a price target of $45, noting the potential of the “differentiated” tech of the firm in the sequencing domain compared to peers. 

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm ARK Investment Management is a leading shareholder in Pacific Biosciences of California, Inc. (NASDAQ:PACB) with 22 million shares worth more than $580 million. 

In its Q1 2021 investor letter, Baron Funds, an asset management firm, highlighted a few stocks and Pacific Biosciences of California, Inc. (NASDAQ:PACB) was one of them. Here is what the fund said:

“Pacific Biosciences of California, Inc. provides long-read DNA sequencing systems to scientists conducting genetic analysis. Shares performed well for the quarter. We believe there is increasing excitement about the potential for its platform to move beyond research into clinical applications. The recently appointed CEO was previously Chief Commercial Officer at Illumina, and we think he is well qualified to commercially execute on Pacific Biosciences’ differentiated long-read platform.”